MEAM Ph.D. Thesis Defense: “Development of Microfluidic Platforms for High-Throughput Biomolecular Screening”
/
Room 2C4, David Rittenhouse Laboratory Building
209 S. 33rd Street, Philadelphia, PA, United States
High-throughput screening (HTS) is an essential step in the discovery and development of novel therapeutics. Single-phase and multiphase microfluidic platforms offer improved sensitivity, reduced cost, and enhanced physiological relevance compared with conventional screening technologies such as microplates and fluorescence-activated cell sorters. However, a challenge towards unlocking the full potential of microfluidic platforms for HTS in […]

